UPDATED May 27, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PRPB | US$9.15 | -2.1% | -6.6% | US$992.8m | US$12.00 | PE-76x | E103.3% | n/a | Diversified Financials | ||
ESPR | US$2.13 | -5.3% | 45.9% | US$403.6m | US$7.41 | PS1.8x | E59.3% | n/a | Pharmaceuticals & Biotech | ||
IOAC | US$9.60 | -16.4% | -6.8% | US$132.8m | n/a | PE-57.8x | n/a | n/a | Diversified Financials | ||
RANI | US$4.44 | -9.9% | 6.0% | US$223.8m | US$10.57 | PB15.8x | E7.6% | n/a | Pharmaceuticals & Biotech | ||
QFTA | US$7.00 | -31.8% | -31.2% | US$70.6m | n/a | PE101x | n/a | n/a | Diversified Financials | ||
LRMR | US$7.08 | -5.2% | 88.3% | US$451.7m | US$20.85 | PB2x | E-14.5% | n/a | Pharmaceuticals & Biotech | ||
NP | US$32.00 | -4.4% | -36.7% | US$537.3m | US$65.00 | PB1.7x | E114.3% | 5.9% | Materials | ||
DMAQ | US$2.96 | -64.7% | -71.1% | US$36.6m | n/a | PE-21.1x | n/a | n/a | Diversified Financials | ||
EQRX | US$2.34 | -2.1% | -36.2% | US$1.1b | n/a | PB1x | S123.3% | n/a | Pharmaceuticals & Biotech | ||
JWAC | US$5.65 | -23.5% | -43.1% | US$102.6m | n/a | PE106.4x | n/a | n/a | Diversified Financials | ||
KROS | US$48.48 | -1.4% | -1.4% | US$1.7b | US$88.78 | PS7475.8x | E16.9% | n/a | Pharmaceuticals & Biotech | ||
NAMS | US$18.82 | -1.5% | 38.7% | US$1.7b | US$34.87 | PS246.8x | E32.0% | n/a | Pharmaceuticals & Biotech | ||
ECX | US$1.15 | -6.5% | -82.2% | US$388.8m | US$4.83 | PE-2.8x | E54.0% | n/a | Automobiles | ||
GXII | US$6.69 | -10.4% | -31.2% | US$250.9m | n/a | PE-31.8x | n/a | n/a | Diversified Financials | ||
RCKT | US$21.42 | -1.4% | 1.0% | US$1.9b | US$50.08 | PB4.4x | E57.3% | n/a | Pharmaceuticals & Biotech | ||
RPT | US$12.83 | -2.5% | 25.9% | US$1.1b | US$11.17 | PB1.3x | E-115.2% | 4.4% | Real Estate | ||
MBII | US$0.80 | -20.2% | -43.4% | US$145.6m | US$1.38 | PS3.3x | E71.8% | n/a | Materials | ||
ACAX | US$3.82 | -62.9% | -62.2% | US$47.4m | n/a | PE20x | n/a | n/a | Diversified Financials | ||
KYCH | US$4.10 | -54.9% | -60.3% | US$54.6m | n/a | PE12x | n/a | n/a | Diversified Financials | ||
SGEN | US$228.74 | -0.07% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
FZT | US$7.76 | -30.9% | -21.1% | US$98.5m | n/a | PE-20.3x | n/a | n/a | Diversified Financials | ||
APPN | US$31.05 | -1.4% | -23.4% | US$2.2b | US$38.67 | PS4x | E35.4% | n/a | Software | ||
FIVN | US$50.04 | -0.9% | -14.9% | US$3.7b | US$83.36 | PS3.9x | E61.9% | n/a | Software | ||
QTTB | US$26.00 | -11.6% | n/a | US$310.5m | US$49.67 | PB6.4x | E-22.2% | n/a | Pharmaceuticals & Biotech |